James G Boyle Selected Research

James G Boyle Research Topics

4	Type 2 Diabetes Mellitus (MODY) 12/2022 - 01/2018
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2022 - 01/2017
1	Weight Gain 12/2022
1	Insulin Resistance 01/2022
1	Schizophrenia (Dementia Praecox) 11/2019
1	Inflammation (Inflammations) 01/2018
1	Body Weight (Weight, Body) 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Overweight 01/2017
1	Atherosclerosis 01/2017
1	Neoplasms (Cancer) 01/2011
1	Infections 04/2008
1	Pheochromocytoma 12/2007

3	Insulin (Novolin)FDA Link 12/2022 - 01/2017
3	Metformin (Glucophage)FDA LinkGeneric 12/2022 - 01/2017
3	Glucose (Dextrose)FDA LinkGeneric 12/2022 - 01/2017
2	LDL CholesterolIBA 01/2018 - 01/2017
2	CatecholaminesIBA 01/2011 - 12/2007
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 12/2022
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 12/2022
1	SodiumIBA 12/2022
1	Islet Amyloid PolypeptideIBA 12/2022
1	dapagliflozinIBA 12/2022
1	pramlintide (Symlin)FDA Link 12/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Testosterone (Sustanon)FDA Link 01/2021
1	Triglycerides (Triacylglycerol)IBA 11/2019
1	CholesterolIBA 11/2019
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2018
1	FlavonolsIBA 01/2011
1	Dopamine (Intropin)FDA LinkGeneric 01/2011
1	Homovanillic AcidIBA 01/2011
1	AMP-Activated Protein KinasesIBA 04/2008
1	Rosiglitazone (Avandia)FDA Link 04/2008
1	mandelic acidIBA 12/2007

3	Therapeutics 12/2022 - 01/2017
1	Glycemic Control 12/2022